|
Market Closed -
Budapest S.E.
08:50:00 16/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 12,470.00 HUF | -1.89% |
|
+0.97% | +26.41% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 11/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Company Valuation: Gedeon Richter
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,19,625 | 15,42,290 | 16,27,029 | 18,93,161 | 17,99,226 | 22,74,410 | - | - |
| Change | - | -4.77% | 5.49% | 16.36% | -4.96% | 26.41% | - | - |
| Enterprise Value (EV) 1 | 15,59,769 | 13,95,557 | 15,46,536 | 17,82,343 | 15,88,618 | 20,11,934 | 18,64,399 | 17,37,431 |
| Change | - | -10.53% | 10.82% | 15.25% | -10.87% | 26.65% | -7.33% | -6.81% |
| P/E | 11.6x | 9.94x | 10.2x | 7.96x | 7.76x | 9.17x | 7.85x | 7.26x |
| PBR | 1.78x | 1.47x | 1.44x | 1.49x | 1.31x | 1.51x | 1.37x | 1.24x |
| PEG | - | 0.9x | 3.41x | 0.2x | -2.82x | 1.32x | 0.5x | 0.9x |
| Capitalization / Revenue | 2.57x | 1.92x | 2.02x | 2.21x | 1.94x | 2.39x | 2.23x | 2.08x |
| EV / Revenue | 2.47x | 1.74x | 1.92x | 2.08x | 1.71x | 2.11x | 1.83x | 1.59x |
| EV / EBITDA | 8.86x | 7.1x | 6.43x | 5.74x | 4.5x | 5.47x | 4.7x | 4.09x |
| EV / EBIT | 11.5x | 9.09x | 8.15x | 6.82x | 5.42x | 6.66x | 5.6x | 4.84x |
| EV / FCF | -460x | 12.3x | 17.9x | 8.26x | 7.56x | 8.91x | 8.13x | 7.02x |
| FCF Yield | -0.22% | 8.12% | 5.6% | 12.1% | 13.2% | 11.2% | 12.3% | 14.2% |
| Dividend per Share 2 | 225 | 390 | - | - | - | 603.6 | 677 | 738.7 |
| Rate of return | 2.58% | 4.7% | - | - | - | 4.84% | 5.43% | 5.92% |
| EPS 2 | 751 | 835 | 860 | 1,307 | 1,271 | 1,359 | 1,589 | 1,718 |
| Distribution rate | 30% | 46.7% | - | - | - | 44.4% | 42.6% | 43% |
| Net sales 1 | 6,30,595 | 8,02,755 | 8,05,158 | 8,57,545 | 9,28,962 | 9,51,368 | 10,20,834 | 10,93,689 |
| EBITDA 1 | 1,76,123 | 1,96,480 | 2,40,625 | 3,10,678 | 3,53,314 | 3,67,576 | 3,96,366 | 4,25,015 |
| EBIT 1 | 1,35,832 | 1,53,555 | 1,89,817 | 2,61,157 | 2,92,851 | 3,02,220 | 3,32,887 | 3,59,032 |
| Net income 1 | 1,39,626 | 1,55,581 | 1,58,850 | 2,39,244 | 2,32,335 | 2,54,304 | 2,90,549 | 3,14,929 |
| Net Debt 1 | -59,856 | -1,46,733 | -80,493 | -1,10,818 | -2,10,608 | -2,62,476 | -4,10,012 | -5,36,980 |
| Reference price 2 | 8,725.00 | 8,300.00 | 8,750.00 | 10,400.00 | 9,865.00 | 12,470.00 | 12,470.00 | 12,470.00 |
| Nbr of stocks (in thousands) | 1,85,630 | 1,85,818 | 1,85,946 | 1,82,035 | 1,82,385 | 1,82,391 | - | - |
| Announcement Date | 02/03/22 | 28/02/23 | 29/02/24 | 07/04/25 | 27/02/26 | - | - | - |
1HUF in Million2HUF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 9.35x | 2.16x | 5.59x | 4.75% | 714.28Cr | |
| 35.8x | 12.9x | 27.02x | 0.55% | 1,11600Cr | |
| 37.07x | 6.25x | 17.38x | 2.11% | 61TCr | |
| 36.17x | 8.31x | 17.13x | 2.45% | 50TCr | |
| 20.49x | 5x | 12.4x | 2.64% | 37TCr | |
| 112.15x | 5.92x | 25.35x | 2.35% | 36TCr | |
| 21.24x | 5.55x | 13.66x | 2.88% | 29TCr | |
| 22x | 4.43x | 12.71x | 1.99% | 26TCr | |
| 27.56x | 7.08x | 12.68x | 2.32% | 23TCr | |
| -45.98x | 7.04x | 27.26x | 2.1% | 20TCr | |
| Average | 27.59x | 6.46x | 17.12x | 2.41% | 39.37TCr | |
| Weighted average by Cap. | 35.00x | 8.16x | 19.95x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RICHTER Stock
- Valuation Gedeon Richter
Select your edition
All financial news and data tailored to specific country editions
